Topics

Pathios Therapeutics announces appointment of Dr. Tobias Bopp as the foundational member of its Scientific Advisory Board

06:56 EST 13 Feb 2020 | OBN

Oxford, UK – 11 February 2020 – Pathios Therapeutics Limited ("Pathios"), an innovative biotech company focused on the development of first-in-class therapies for cancer and autoimmune diseases, today announced that it has appointed Dr. Tobias Bopp, a leading academic and pioneer in the study of the influence of acidosis on tumour immunology, as the foundational member of its Scientific Advisory Board.

Original Article: Pathios Therapeutics announces appointment of Dr. Tobias Bopp as the foundational member of its Scientific Advisory Board

NEXT ARTICLE

More From BioPortfolio on "Pathios Therapeutics announces appointment of Dr. Tobias Bopp as the foundational member of its Scientific Advisory Board"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...